
These are the 100 most influential people who are influencing the corporate venturing industry.
These are the 50 early-career professionals who are rising fast in the corporate venturing industry.
These are the 50 mid-career professionals who are influencing the corporate venturing industry.
These are the 100 most influential people who are influencing the corporate venturing industry.
These are the 50 mid-career professionals who are influencing the corporate venturing industry.
These are the 50 early-career professionals who are rising fast in the corporate venturing industry.
This special quarterly report for both the Global Healthcare Council and Global AI Council picks up how developments in one field are increasingly relevant for others.
May 2022 issue editorial by James Mawson, editor-in-chief, Global Corporate Venturing
GCV Powerlist 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing
Global Energy Council Q2 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing
April 2022 editorial by James Mawson, editor-in-chief, Global Corporate Venturing
Oncology Q1 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing
GCV Mobility Q1 2022 supplement editorial by James Mawson, editor in chief, Global Corporate Venturing
March 2022 editorial by James Mawson, editor-in-chief, Global Corporate Venturing
The corporate venturing industry is pushing towards a 50:50 split in senior investor roles.
A decade's focus on digitalisation leaves physical assets vulnerable.
In the first part of our look at 2021's corporate venturing trends, we examine the growth in funding, IPOs and SPAC mergers, a big year for M&A and the emergence of CVC in new sectors.
GEC Healthcare Q1 2021 forward by Rob Coppedge, chief executive, Echo Health Ventures, and Bill Taranto, and president, Merck Global Health Innovation Fund